Advertisement

The Influence of Complement Receptors on the Localization of Lymphocytes in Vivo

  • G. Kraal
  • I. van Hoogstraten

Abstract

T and B lymphocytes entering the spleen leave the blood stream in the sinuses of the marginal zone and will migrate from there into the white pulp of the spleen1. It has been demonstrated that there is a preference of B cells to localize in the spleen2–4 which is comparable to the localization patterns of lymphocytes in Peyer’s patches2. The splenic immigration of T-cell subsets, however, is more comparable with peripheral lymph nodes5. The selective entrance of T and B cells in the spleen is therefore different from that in the high endothelial venule (HEV)-bearing lymphoid organs such as lymph nodes and Peyer’s patches. How this selection in the spleen is accomplished is not known. In the marginal zone various macrophages can be identified6, 7 and it has been suggested that these cells play a role in lymphocyte traffic8–10. Macrophages can be influenced by complement factors11 and we therefore approached the question of selective lymphocyte migration in the spleen by looking at the effects of complement depletion by Cobra Venom (CVF) administration.

Keywords

Cell Transfer High Endothelial Venule Normal Mouse Serum Cobra Venom Cobra Venom Factor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    P. Nieuwenhuis, and W.L. Ford. Cell. Immunol. 23: 254 (1976).PubMedCrossRefGoogle Scholar
  2. 2.
    G.A. Gutman, and I.L. Weissman. Transplantation 16: 621 (1973).PubMedCrossRefGoogle Scholar
  3. 3.
    J. Sprent. Cell. Immunol. 7: 10 (1973).PubMedCrossRefGoogle Scholar
  4. 4.
    S.K. Stevens, I.L. Weissman, and E.C. Butcher. J. Immunol. 128: 844 (1982).PubMedGoogle Scholar
  5. 5.
    G. Kraal, I.L. Weissman, and E.C. Butcher. J. Immunol. 130: 1097 (1983).PubMedGoogle Scholar
  6. 6.
    J.H. Humphrey, and D. Grennan. Eur. J. Immunol. 11: 221 (1981).PubMedCrossRefGoogle Scholar
  7. 7.
    C.D. Dijkstra, E. van Vliet, E.A. Düpp, G. v. d. Lelij, and G. Kraal. Immunology, in press.Google Scholar
  8. 8.
    W.L. Ford. Progr. Allergy 19: 1 (1975).Google Scholar
  9. 9.
    A.A. Freitas, and M. de Sousa. Eur. J. Immunol. 6: 629 (1976).Google Scholar
  10. 10.
    R. Brelinska, and Ch. Pilgrim. Cell Tissue Res. 233: 671 (1983).PubMedCrossRefGoogle Scholar
  11. 11.
    B. Rutherford, and H.A. Schenkein. J. Immunol. 130: 874 (1983).PubMedGoogle Scholar
  12. 12.
    M. Ballow, and Ch.G. Cochrane. J. Immunol. 103: 944 (1969).PubMedGoogle Scholar
  13. 13.
    H. van Dijk, P.M. Rademaker, and J.M.N. Willers. J. Immunol. Meth. 36: 29 (1980).CrossRefGoogle Scholar
  14. 14.
    H. van Dijk, D. van Heuven-Nolsen, P.M. Rademaker, N. Bloksma, and J.M.N. Willers. Cell. Immunol. 51: 402 (1980).PubMedCrossRefGoogle Scholar
  15. 15.
    C. Bianco, R. Patrick, and V. Nussenzweig. J. Exp. Med. 132: 702 (1970).PubMedCrossRefGoogle Scholar
  16. 16.
    T.E. Jessen, V. Barkholt, and K.L. Welinder. J. Immunol. Meth. 60: 89 (1983).CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1958

Authors and Affiliations

  • G. Kraal
    • 1
  • I. van Hoogstraten
    • 1
  1. 1.Department of Histology, Medical FacultyFree UniversityAmsterdamThe Netherlands

Personalised recommendations